Gsa Capital Partners LLP Syneos Health, Inc. Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$34.5 - $42.19 $263,649 - $322,415	7,642 New	7,642 $322,000
Q4 2022 Feb 13, 2023	BUY	$25.32 - $51.45 $410,741 - $834,621	16,222 New	16,222 $595,000
Q4 2020 Feb 03, 2021	SELL	$53.08 - $69.86 $710,953 - $935,704	-13,394 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$51.29 - $65.09 $686,978 - $871,815	13,394 New	13,394 $712,000
Q1 2020 May 12, 2020	SELL	$32.64 - $73.63 $780,324 - $1.76 Million	-23,907 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$48.0 - $59.55 $151,968 - $188,535	3,166 Added 15.26%	23,907 $1.42 Million
Q3 2019 Nov 12, 2019	SELL	$46.64 - $55.39 $37,871 - $44,976	-812 Reduced 3.77%	20,741 $1.1 Million
Q2 2019 Aug 06, 2019	SELL	$40.81 - $52.42 $559,301 - $718,416	-13,705 Reduced 38.87%	21,553 $1.1 Million
Q1 2019 May 15, 2019	BUY	$36.91 - $55.7 $306,574 - $462,644	8,306 Added 30.82%	35,258 $1.83 Million
Q4 2018 Feb 12, 2019	BUY	$36.49 - $51.72 $983,478 - $1.39 Million	26,952 New	26,952 $1.06 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.